TABLE 2.
The possible physiological processes regulated by PAQR3 in lung cancer via GSEA.
| Name | Size | ES | NES | NOM p |
| KEGG_CELL_CYCLE | 124 | 0.603 | 2.062 | 0.002 |
| KEGG_CHRONIC_MYELOID_LEUKEMIA | 73 | 0.503 | 1.920 | 0.000 |
| KEGG_PYRIMIDINE_METABOLISM | 97 | 0.513 | 1.918 | 0.002 |
| KEGG_DNA_REPLICATION | 36 | 0.766 | 1.917 | 0.002 |
| KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS | 130 | 0.490 | 1.914 | 0.000 |
| KEGG_SPLICEOSOME | 124 | 0.624 | 1.886 | 0.015 |
| KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 85 | 0.517 | 1.882 | 0.000 |
| KEGG_COLORECTAL_CANCER | 62 | 0.501 | 1.872 | 0.000 |
| KEGG_BASAL_TRANSCRIPTION_FACTORS | 34 | 0.605 | 1.870 | 0.000 |
| KEGG_BASE_EXCISION_REPAIR | 34 | 0.596 | 1.867 | 0.004 |
| KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 76 | 0.495 | 1.851 | 0.000 |
| KEGG_HOMOLOGOUS_RECOMBINATION | 26 | 0.651 | 1.823 | 0.012 |
| KEGG_RNA_DEGRADATION | 54 | 0.579 | 1.823 | 0.008 |
| KEGG_MISMATCH_REPAIR | 23 | 0.693 | 1.817 | 0.006 |
| KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 125 | 0.458 | 1.816 | 0.002 |
| KEGG_P53_SIGNALING_PATHWAY | 65 | 0.476 | 1.800 | 0.004 |
| KEGG_ERBB_SIGNALING_PATHWAY | 86 | 0.456 | 1.780 | 0.002 |
| KEGG_RNA_POLYMERASE | 29 | 0.619 | 1.779 | 0.020 |
| KEGG_GAP_JUNCTION | 88 | 0.444 | 1.758 | 0.000 |
| KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 78 | 0.460 | 1.729 | 0.000 |
| KEGG_OOCYTE_MEIOSIS | 111 | 0.462 | 1.728 | 0.010 |
| KEGG_GLIOMA | 65 | 0.456 | 1.716 | 0.004 |
| KEGG_NON_SMALL_CELL_LUNG_CANCER | 54 | 0.464 | 1.706 | 0.008 |
| KEGG_LONG_TERM_POTENTIATION | 70 | 0.462 | 1.678 | 0.006 |
| KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 107 | 0.425 | 1.676 | 0.008 |
| KEGG_LYSINE_DEGRADATION | 39 | 0.516 | 1.674 | 0.015 |
| KEGG_PANCREATIC_CANCER | 69 | 0.428 | 1.666 | 0.004 |
| KEGG_TYPE_II_DIABETES_MELLITUS | 47 | 0.480 | 1.665 | 0.006 |
| KEGG_NUCLEOTIDE_EXCISION_REPAIR | 44 | 0.535 | 1.664 | 0.027 |
| KEGG_INSULIN_SIGNALING_PATHWAY | 137 | 0.399 | 1.651 | 0.004 |
| KEGG_MTOR_SIGNALING_PATHWAY | 51 | 0.466 | 1.642 | 0.014 |
| KEGG_PURINE_METABOLISM | 153 | 0.412 | 1.620 | 0.028 |
| KEGG_PROSTATE_CANCER | 89 | 0.406 | 1.616 | 0.012 |
| KEGG_ACUTE_MYELOID_LEUKEMIA | 57 | 0.432 | 1.605 | 0.016 |
| KEGG_LONG_TERM_DEPRESSION | 67 | 0.433 | 1.602 | 0.006 |
| KEGG_TASTE_TRANSDUCTION | 51 | 0.593 | 1.592 | 0.008 |
| KEGG_AXON_GUIDANCE | 128 | 0.398 | 1.575 | 0.012 |
| KEGG_VEGF_SIGNALING_PATHWAY | 75 | 0.414 | 1.570 | 0.006 |
| KEGG_RENAL_CELL_CARCINOMA | 66 | 0.428 | 1.559 | 0.019 |
| KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 93 | 0.392 | 1.548 | 0.014 |
| KEGG_INOSITOL_PHOSPHATE_METABOLISM | 54 | 0.424 | 1.543 | 0.020 |
| KEGG_GNRH_SIGNALING_PATHWAY | 100 | 0.395 | 1.541 | 0.010 |
| KEGG_ENDOMETRIAL_CANCER | 52 | 0.430 | 1.530 | 0.027 |
| KEGG_MAPK_SIGNALING_PATHWAY | 265 | 0.341 | 1.514 | 0.004 |
| KEGG_WNT_SIGNALING_PATHWAY | 150 | 0.346 | 1.489 | 0.018 |
| KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION | 67 | 0.387 | 1.478 | 0.019 |
| KEGG_CHEMOKINE_SIGNALING_PATHWAY | 184 | 0.340 | 1.430 | 0.023 |
| KEGG_GLYCEROLIPID_METABOLISM | 43 | 0.403 | 1.420 | 0.049 |
ES, enrichment score; NES, normalized enrichment score; NOM p, nominal p-value.